Mylan cuts patient cost of EpiPen

(Reuters) - Mylan NV said it would reduce the patient cost of its severe allergy treatment drug EpiPen on Thursday, a day after Democratic Presidential candidate Hillary Clinton called for lower pricing of the drug.

Mylan cuts patient cost of EpiPen
Read More


Bagikan Berita Ini